Moderated Poster

Poster, Podium & Video Sessions

MP41-03: Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients

Saturday, May 13
3:30 PM - 5:30 PM
Location: BCEC: Room 156

Presentation Authors: Ghasem Solgi, Hamedan, Islamic Republic of Iran, Vijayakrishna Gadi, Gholamreza Pourmand*, Abdolrasoul Mehrsai, Moslem Ranjbar, Mousa Mohammadnia, Behrouz Nikbin, Ali Akbar Amirzargar, Tehran, Islamic Republic of Iran

Introduction: Augmentation of microchimerism in solid organ transplant recipients by donor bone marrow cells (DBMC) infusion may promote immune hyporesponsiveness and consequently improve long-term allograft survival.

Methods: Between March 2005 and July 2007, outcomes for 20 living unrelated donor (LURD) primary kidney recipients with concurrent DBMC infusion (an average of 2.19 ± 1.13 x 109 donor cells consisting of 2.66 ± 1.70 x 107 CD34+ cells) were prospectively compared with 20 non-infused control allograft recipients given similar conventional immunosuppressive regimens.

Results: With five years of clinical follow up, a total of 11 cases experienced rejection episodes (3 DBMI patients vs. 8 controls, p = 0.15). One DBMCinfused iopsy-confirmed) in the control patients. Actuarial and death-censored 5-y graft survival was significantly higher in infused patients compared with controls (p = 0.01 and p = 0.03, respectively). Long-term graft survival was significantly associated with pre-transplant anti-HLA antibodies (p= 0.01), slightly with peripheral microchimerism (p = 0.09) and CD4+CD25+FoxP3+ T cells (p = 0.09). Immunosuppressant dosing was lower in infused patients than controls, particularly for mycophenolate mofetil (p = 0.001).

Conclusions: The current findings as well as our previous reports on these patients indicates clinical improvement in long-term graft survival of renal transplant patients resulting from low-dose DBMC infusion given without induction therapy.

Source Of Funding: none

Send Email for Gholamreza Pourmand


Assets

MP41-03: Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients



Attendees who have favorited this

Send Email for Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients